Clinical Trial

Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2)

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is a multicenter, long-term, follow-up trial of participants with Gaucher disease type 1 who received FLT201 treatment in a preceding clinical trial. Participants will be followed for 5 years post-treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-06.
Status change: Recruiting → Active, Not Recruiting 2025-10-31
Trial Details
NCT Number NCT06545136
Lead Sponsor Spur Therapeutics
Conditions Gaucher Disease, Type 1
Enrollment 75 participants
Start Date 2024-05-13
Primary Completion 2029-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2025-11-04